Anticancer Activity of an Oligopeptide Isolated from Hydrolysates of Sepia Ink

Chinese Journal of Natural Medicines

Volumn 9, Issue 2, 2011, Pages 151-155

  Ding, Guo Fang ^a   Huang, Fang Fang ^a   Yang, Zui Su ^a   Yu, Di ^a   Yang, Yong Fang ^a  

^a ZHEJIANG OCEAN UNIVERSITY   (China)

Author keywords

Antitumor; Enzymatic hydrolysis; N Gln Pro Lys; Oligopeptide; Sepia ink

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; INK; OLIGOPEPTIDE; TRYPSIN;

AMINO ACID SEQUENCE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ASSAY; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CUTTLEFISH; GEL FILTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROLYSIS; MALE; MOLECULAR WEIGHT; PURIFICATION; STAINING; ULTRAFILTRATION;

EID: 79956326086     PISSN: 20956975     EISSN: 18755364     Source Type: Journal    
DOI: 10.3724/SP.J.1009.2011.00151     Document Type: Article

References (25)

1. Sanjay G, Alain CM, Monica M, et al. A phase I study of eribulin mesylate (E7389), a mechanistically novel inhibitor of microtubule dynamics, in patients with advanced solid malignancies [J]. Clin Cancer Res 2009, 15(12):4207-4212.
2. Boris AH, Hans A, Ladan F, et al. Intravesical chemotherapy of high-grade bladder cancer with HTI-286, A Synthetic analogue of the marine sponge product hemiasterlin [J]. Clin Cancer Res 2008, 14(5):1510-1518.
3. Monique WJ, Den B, Bastiaan N, et al. Pharmaceutical development of a parenteral lyophilised formulation of the investigational anticancer agent ES-285.HCl [J]. PDA J Pharm Sci Technol 2005, 59(4):246-257.
4. Luesch H, Moore RE, Paul VJ, et al. Isolation of dolastatin 10 analogue from the marine cyanobacterium symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1 [J]. J Nat Prod 2001, 64(7):907-910.
5. Hoffman M, Blessing J, Lentz S A phase II trial of dolastatin-10 in recurrent platinum-sensitive ovarian carcinoma: a gynecologic oncology group study [J]. Gynecol Oncol 2003, 89(1):95-98.
6. Simmons TL, Andrianasolo E, McPhail K, et al. Marine natural products as anticancer drugs [J]. Mol Cancer Ther 2005, 4(2):333-342.
7. Zhang YK, Zhang DX Progress in study on antitumor effect and mechanism of bioactive peptides [J]. Chin J Biochem Pharm 2006, 27(6):379-382.
8. Song L, Li TF, Yu RM, et al. Antioxidant activities of hydrolysates of Arca subcrenata prepared with three proteases [J]. Mar Drugs 2008, 6(4):607-679.
9. Chen CH, Chi JG, Qiu WZ, et al. A survey of peptide drugs [J]. Shandong Sci 2008, 21(3):42-49.
10. Zeng MJ, Zhang DM, Chen JH, et al. Research advances of antitumor peptides [J]. Chin J Biochem Pharm 2007, 28(2):139-141.
11. Yao Z, Qiu S, Wang L, et al. Tripeptide tyroserleutide enhances the antitumor effects of macrophages and stimulates macrophage secretion of IL-1β, TNF-α, and NO in vitro [J]. Cancer Immunol Immunother 2006, 55(1):56-60.
12. Zhong JP, Wang G, Shang JH, et al. Protective effects of Squid ink extract towards hemopoietic injuries induced by cyclophosphamine [J]. Mar Drugs 2009, 7(1):9-18.
13. Tetsushi N, Hun-Sik C, Hidemitsu U, et al. Tyrosinase activity in antitumor compounds of Squid ink [J]. Food Sci Technol Rcs 2000, 6(3):171-175.
14. Leng BO, Xiao DL, Qing XC Inhibitory effects of anticancer peptide from Mercenaria on the BGC-823 cells and several enzymes [J]. FEBS Lett 2005, 579(5):1187-1190.
15. Zhang B, Wu WT Isolation and characterization of glycopeptide MGP0405 from Meretrix meretrix [J]. Chin J Nat Med 2006, 4(3):230-233.
16. Liu XD, Qiu L, Wu Q Studies on the physiological activity of a natural peptide from clam (Meretrix meretrix Linnaeus) [J]. J Xiamen Univ (Nat Sci) 2004, 43(4):432-435.
17. Pettit GR, Kamano Y, Herald CL, et al. Symplostatin: a dolastatin 10 from the marine cyanobacterium symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1 [J]. J Amchem Soc 1987, 109(22):6883-6885.
18. Andersen SO, Roepstorff P Sclerotization of insect cuticle-III. An unsaturated derivative of N-acetyldopaminc and its role in sclerotization [J]. Insect Biochem 1982, 12(3):269-276.
19. Takaya Y, Uchisawa H, Hanamatsu K, et al. Novel fucose-rich glycosaminoglycans from squid ink bearing repeating unit of trisaccharide structure(-6Gal-NAcα1-3GlcAβ1-3Fucα-1)n [J]. Biochem Biophys Res Commun 1997, 198(2):560-567.
20. Takaya Y, Uchisawa H, Narumi F, et al. Illexins A, B and C from Squid ink should have a branched structure [J]. Biochem Biophys Res Commun 1996, 226(2):335-338.
21. Lee YG, Lee KW, Kim JY, et al. Induction of apoptosis in a human lymphoma cell line by hydrophobic peptide fraction separated from anchovy sauce [J]. Biofactor 2004, 21(2):63-67.
22. Kim SE, Kim HH, Kim JY, et al. Anticancer activity of hydrophobic peptides from soy proteins [J]. Biofactor 2000, 21(1):63-67.
23. De Lumen BO Lunasin: A cancer-preventive soy peptide [J]. Nutr rev 2005, 63(1):16-21.
24. Wakabayashi H, Yamauchi K, Takade ML Actoferrin research, technology and applications [J]. Int Dairy J 2006, 16(11):1241-1251.
25. Jang A, Jo C, Kang KS, et al. Angiotensin-converting enzyme (ACE) inhibitory peptides [J]. Food Chem 2008, 107(1):327-336.